| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2016-10-14 Tx date 2016-10-05 |
$IMU
bioMmune Technologies Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+142,000 vol |
467,000 | |
| Filed 2016-10-14 Tx date 2016-10-05 |
$IMU
bioMmune Technologies Inc. |
Gadek, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
| Filed 2016-10-14 Tx date 2016-09-20 |
$IMU
bioMmune Technologies Inc. |
Gadek, Thomas
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-22 Tx date 2016-04-22 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+23,333 vol |
669,999 | |
| Filed 2016-04-05 Tx date 2015-11-19 |
$IMU
bioMmune Technologies Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-04-05 Tx date 2016-04-01 |
$IMU
bioMmune Technologies Inc. |
Pearson, Terry
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
195,000 | |
| Filed 2016-04-05 Tx date 2016-04-01 |
$IMU
bioMmune Technologies Inc. |
Nikolich, Karoly
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+202,500 vol |
352,500 | |
| Filed 2016-04-05 Tx date 2016-04-01 |
$IMU
bioMmune Technologies Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+325,000 vol |
325,000 | |
| Filed 2016-04-05 Tx date 2016-04-01 |
$IMU
bioMmune Technologies Inc. |
Gabathuler, Reinhard
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+135,000 vol |
535,000 | |
| Filed 2016-04-05 Tx date 2016-04-01 |
$IMU
bioMmune Technologies Inc. |
DALLING, JUDI
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+90,000 vol |
265,000 | |
| Filed 2016-04-05 Tx date 2016-04-01 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+22,500 vol |
422,500 | |
| Filed 2016-03-04 Tx date 2016-03-01 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+36,000 vol |
110,000 | |
| Filed 2016-02-16 Tx date 2016-02-12 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+4,000 vol |
74,000 | |
| Filed 2016-02-05 Tx date 2016-02-02 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+10,000 vol |
70,000 | |
| Filed 2016-02-01 Tx date 2016-01-27 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
+5,000 vol |
646,666 | |
| Filed 2016-01-26 Tx date 2016-01-22 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+10,000 vol |
60,000 | |
| Filed 2016-01-08 Tx date 2015-11-19 |
$IMU
bioMmune Technologies Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
166,667 | ||
| Filed 2016-01-08 Tx date 2015-11-19 |
$IMU
bioMmune Technologies Inc. |
Gray, Patrick
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
166,667 | ||
| Filed 2015-11-30 Tx date 2015-11-19 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
+50,000 vol |
50,000 | |
| Filed 2015-11-30 Tx date 2015-06-30 |
$IMU
bioMmune Technologies Inc. |
BIERTUMPEL, JENS
4 - Director of Issuer
Holder: Tanis Churchill (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|